#	Aladdin ID	Assay Type	Description	Organism	Compounds	Reference	BAO Format	Source
1.	ALA4767558	Binding	Inhibition of mouse GAT3 expressed in HEK293 cell line assessed as inhibition of [3H]GABA uptake measured after 35 mins by liquid scintillation method	Mus musculus	32	ALA4765247	cell-based format	Scientific Literature
2.	ALA4767559	Binding	Inhibition of mouse GAT2 expressed in HEK293 cell line assessed as inhibition of [3H]GABA uptake measured after 35 mins by liquid scintillation method	Mus musculus	29	ALA4765247	cell-based format	Scientific Literature
3.	ALA4767560	Binding	Inhibition of mouse GAT1 expressed in HEK293 cell line assessed as inhibition of [3H]GABA uptake measured after 35 mins by liquid scintillation method	Mus musculus	31	ALA4765247	cell-based format	Scientific Literature
4.	ALA4767561	Functional	Antiallodynic activity in STZ-induced diabetic neuropathy pain Albino Swiss mouse model assessed as reduced tactile allodynia at 5 mg/kg, ip administered after 3 weeks of STZ stimulation and measured after 1 hr by von Frey test	Mus musculus	2	ALA4765247	organism-based format	Scientific Literature
5.	ALA4767562	Functional	Antiallodynic activity in STZ-induced diabetic neuropathy pain Albino Swiss mouse model assessed as reduced tactile allodynia at 10 mg/kg, ip administered after 3 weeks of STZ stimulation and measured after 1 hr by von Frey test	Mus musculus	2	ALA4765247	organism-based format	Scientific Literature
6.	ALA4767563	Functional	Antiallodynic activity in STZ-induced diabetic neuropathy pain Albino Swiss mouse model assessed as reduced tactile allodynia at 30 mg/kg, ip administered after 3 weeks of STZ stimulation and measured after 1 hr by von Frey test	Mus musculus	2	ALA4765247	organism-based format	Scientific Literature
7.	ALA4767564	Functional	Antihyperalgesic activity in STZ-induced diabetic neuropathy pain Albino Swiss mouse model assessed as reduced heat nociceptive threshold at 10 mg/kg, ip administered after 3 weeks of STZ stimulation and measured after 1 hr by hot plate method	Mus musculus	2	ALA4765247	organism-based format	Scientific Literature
8.	ALA4767565	Functional	Antihyperalgesic activity in STZ-induced diabetic neuropathy pain Albino Swiss mouse model assessed as reduced heat nociceptive threshold at 30 mg/kg, ip administered after 3 weeks of STZ stimulation and measured after 1 hr by hot plate method	Mus musculus	2	ALA4765247	organism-based format	Scientific Literature
9.	ALA4767566	Functional	Antiallodynic activity in oxaliplatin-induced diabetic neuropathy pain Albino Swiss mouse model assessed as reduced acute-phase tactile allodynia at 10 mg/kg, ip administered after 3 hrs of oxaliplatin stimulation and measured after 1 hr by von Frey test	Mus musculus	1	ALA4765247	organism-based format	Scientific Literature
10.	ALA4767567	Functional	Antiallodynic activity in oxaliplatin-induced diabetic neuropathy pain Albino Swiss mouse model assessed as reduced acute-phase tactile allodynia at 30 mg/kg, ip administered after 3 hrs of oxaliplatin stimulation and measured after 1 hr by von Frey test	Mus musculus	2	ALA4765247	organism-based format	Scientific Literature
11.	ALA4767568	Functional	Antiallodynic activity in oxaliplatin-induced diabetic neuropathy pain Albino Swiss mouse model assessed as reduced late-phase tactile allodynia at 30 mg/kg, ip administered after 7 days of oxaliplatin stimulation by van Frey test	Mus musculus	2	ALA4765247	organism-based format	Scientific Literature
12.	ALA4767569	Functional	Antihyperalgesic activity in oxaliplatin-induced diabetic acute neuropathy pain Albino Swiss mouse model assessed as reduction in cold allodynia at 10 mg/kg, ip administered after 3 hrs of oxaliplatin stimulation by cold plate method	Mus musculus	2	ALA4765247	organism-based format	Scientific Literature
13.	ALA4767570	Functional	Antihyperalgesic activity in oxaliplatin-induced diabetic acute neuropathy pain Albino Swiss mouse model assessed as reduction in cold allodynia at 30 mg/kg, ip administered after 3 hrs of oxaliplatin stimulation by cold plate method	Mus musculus	2	ALA4765247	organism-based format	Scientific Literature
14.	ALA4767571	Functional	Antihyperalgesic activity in oxaliplatin-induced diabetic late neuropathy pain Albino Swiss mouse model assessed as reduction in cold allodynia at 10 mg/kg, ip administered after 7 days of oxaliplatin stimulation by cold plate method	Mus musculus	2	ALA4765247	organism-based format	Scientific Literature
15.	ALA4767572	Functional	Antihyperalgesic activity in oxaliplatin-induced diabetic late neuropathy pain Albino Swiss mouse model assessed as reduction in cold allodynia at 30 mg/kg, ip administered after 7 days of oxaliplatin stimulation by cold plate method	Mus musculus	2	ALA4765247	organism-based format	Scientific Literature
16.	ALA4767573	Physicochemical	Lipophilicity, logP of the compound by UPLC-MS method		23	ALA4765247	small-molecule physicochemical format	Scientific Literature
17.	ALA4767587	Functional	Antiallodynic activity in oxaliplatin-induced diabetic neuropathy pain Albino Swiss mouse model assessed as reduced late-phase tactile allodynia at 30 mg/kg, ip administered after 3 hrs of oxaliplatin stimulation and measured after 1 hr by van Frey test	Mus musculus	1	ALA4765247	organism-based format	Scientific Literature
18.	ALA4767588	Binding	Inhibition of mouse GAT4 expressed in HEK293 cell line assessed as inhibition of [3H]GABA uptake measured after 35 mins by liquid scintillation method	Mus musculus	32	ALA4765247	cell-based format	Scientific Literature
19.	ALA4767589	Binding	Displacement of [3H]NO711 from mouse GAT1 expressed in HEK293 cells at 100 uM measured after 40 mins of incubation by LC-ESI-MS-MS method	Mus musculus	19	ALA4765247	cell-based format	Scientific Literature